Alpha Cognition Inc (TSE:ACOG) has released an update.
Alpha Cognition Inc., a biopharmaceutical company, has successfully completed a bridge financing round, raising $4.545 million through convertible notes and warrants. The funding attracted both existing and new investors, with the notes set to mature in 2026 and bearing a 10% annual interest, payable in common shares. This strategic financial move is aimed at bolstering the company’s development of therapies for neurodegenerative disorders.
For further insights into TSE:ACOG stock, check out TipRanks’ Stock Analysis page.
